SCHEMBL6197854

SCHEMBL6197854

CCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1C(=O)Nc1c(C(N)=O)c(-c2ccccc2)nn1CC

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
POLB P06746 2/20 0.53
PDE5A O76074 3/20 0.47
RXFP1 Q9HBX9 1/20 0.41
TSHR P16473 4/20 0.41
LMNA P02545 3/20 0.41
HTT P42858 1/20 0.41
MAPK1 P28482 2/20 0.40
GBA1 P04062 1/20 0.40
RAB9A P51151 1/20 0.40
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7304817 0.83 PDE5A (0.56) KMT2AMEN1POLBPDE5AGBA1
SCHEMBL6199066 0.83 KMT2A (0.58) KMT2APOLBPDE5ARXFP1RAB9A
SCHEMBL6197039 0.83 KMT2A (0.53) KMT2AMEN1POLBPDE5ARXFP1
SCHEMBL6201352 0.82 KMT2A (0.51) KMT2AMEN1POLBPDE5ARXFP1
SCHEMBL6194105 0.78 KMT2A (0.45) KMT2AMEN1POLBPDE5ARXFP1
SCHEMBL6332500 0.77 KMT2A (0.52) KMT2AMEN1POLBPDE5ARXFP1
SCHEMBL7002737 0.76 KMT2A (0.53) KMT2AMEN1POLBPDE5ARXFP1
SCHEMBL5875796 0.76 MEN1 (0.60) KMT2AMEN1POLBTSHRLMNA
SCHEMBL4565717 0.75 TERT (0.56) KMT2AMEN1POLBPDE5ACA12
SCHEMBL6194610 0.74 KMT2A (0.53) KMT2AMEN1POLBPDE5ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0995751-B1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER (US) 2005-06-29 EP disclosed